nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.0373	0.0764	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.0334	0.0686	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.0321	0.0657	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.0271	0.0556	CbGpPWpGaD
Tazarotene—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0244	0.05	CbGpPWpGaD
Tazarotene—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.0222	0.0455	CbGpPWpGaD
Tazarotene—Skin hyperpigmentation—Procarbazine—brain cancer	0.0204	0.0706	CcSEcCtD
Tazarotene—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.0189	0.0388	CbGpPWpGaD
Tazarotene—RXRB—telencephalon—brain cancer	0.0166	0.0744	CbGeAlD
Tazarotene—Skin hyperpigmentation—Hydroxyurea—brain cancer	0.0158	0.0547	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—ESR2—brain cancer	0.0158	0.0323	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—ESR2—brain cancer	0.0141	0.029	CbGpPWpGaD
Tazarotene—RARA—telencephalon—brain cancer	0.0139	0.0621	CbGeAlD
Tazarotene—RXRB—Nuclear Receptors—ESR2—brain cancer	0.0136	0.0278	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—ESR2—brain cancer	0.0136	0.0278	CbGpPWpGaD
Tazarotene—Blister—Hydroxyurea—brain cancer	0.013	0.0451	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Carmustine—brain cancer	0.0128	0.0442	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.0125	0.0256	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.0117	0.024	CbGpPWpGaD
Tazarotene—RARA—gonad—brain cancer	0.0116	0.0518	CbGeAlD
Tazarotene—RARB—endocrine gland—brain cancer	0.0114	0.0511	CbGeAlD
Tazarotene—RARA—pituitary gland—brain cancer	0.0113	0.0506	CbGeAlD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.0113	0.0231	CbGpPWpGaD
Tazarotene—RARB—head—brain cancer	0.0113	0.0504	CbGeAlD
Tazarotene—RARB—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.0112	0.0229	CbGpPWpGaD
Tazarotene—Burning sensation—Carmustine—brain cancer	0.0109	0.0378	CcSEcCtD
Tazarotene—RARA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.0107	0.022	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.0107	0.022	CbGpPWpGaD
Tazarotene—RXRB—endocrine gland—brain cancer	0.0105	0.0469	CbGeAlD
Tazarotene—RXRB—head—brain cancer	0.0104	0.0463	CbGeAlD
Tazarotene—RARB—cerebellum—brain cancer	0.0101	0.045	CbGeAlD
Tazarotene—Haemoglobin—Lomustine—brain cancer	0.00965	0.0334	CcSEcCtD
Tazarotene—Haemorrhage—Lomustine—brain cancer	0.0096	0.0332	CcSEcCtD
Tazarotene—RXRB—central nervous system—brain cancer	0.00945	0.0423	CbGeAlD
Tazarotene—RXRB—cerebellum—brain cancer	0.00924	0.0413	CbGeAlD
Tazarotene—RARG—head—brain cancer	0.00919	0.0411	CbGeAlD
Tazarotene—Skin exfoliation—Hydroxyurea—brain cancer	0.00897	0.031	CcSEcCtD
Tazarotene—RARA—endocrine gland—brain cancer	0.00875	0.0392	CbGeAlD
Tazarotene—RARA—head—brain cancer	0.00864	0.0387	CbGeAlD
Tazarotene—RARG—central nervous system—brain cancer	0.00839	0.0375	CbGeAlD
Tazarotene—RXRB—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00837	0.0172	CbGpPWpGaD
Tazarotene—RARG—cerebellum—brain cancer	0.0082	0.0367	CbGeAlD
Tazarotene—RARB—brain—brain cancer	0.00817	0.0365	CbGeAlD
Tazarotene—RARA—central nervous system—brain cancer	0.00789	0.0353	CbGeAlD
Tazarotene—RARA—cerebellum—brain cancer	0.00771	0.0345	CbGeAlD
Tazarotene—RXRB—brain—brain cancer	0.0075	0.0336	CbGeAlD
Tazarotene—Skin exfoliation—Carmustine—brain cancer	0.00725	0.0251	CcSEcCtD
Tazarotene—Dermatitis bullous—Hydroxyurea—brain cancer	0.00713	0.0247	CcSEcCtD
Tazarotene—Skin exfoliation—Temozolomide—brain cancer	0.007	0.0243	CcSEcCtD
Tazarotene—Photosensitivity reaction—Procarbazine—brain cancer	0.00695	0.0241	CcSEcCtD
Tazarotene—Pain—Carboplatin—brain cancer	0.00667	0.0231	CcSEcCtD
Tazarotene—RARG—brain—brain cancer	0.00666	0.0298	CbGeAlD
Tazarotene—Skin discolouration—Etoposide—brain cancer	0.0065	0.0225	CcSEcCtD
Tazarotene—RARA—brain—brain cancer	0.00626	0.028	CbGeAlD
Tazarotene—Swelling—Carmustine—brain cancer	0.00625	0.0216	CcSEcCtD
Tazarotene—Haemoglobin—Procarbazine—brain cancer	0.00612	0.0212	CcSEcCtD
Tazarotene—Haemorrhage—Procarbazine—brain cancer	0.00609	0.0211	CcSEcCtD
Tazarotene—Inflammation—Etoposide—brain cancer	0.00605	0.021	CcSEcCtD
Tazarotene—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00563	0.0115	CbGpPWpGaD
Tazarotene—Skin exfoliation—Etoposide—brain cancer	0.0056	0.0194	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.00527	0.0108	CbGpPWpGaD
Tazarotene—Dry skin—Temozolomide—brain cancer	0.00488	0.0169	CcSEcCtD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00487	0.00998	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00486	0.00996	CbGpPWpGaD
Tazarotene—Swelling—Etoposide—brain cancer	0.00483	0.0167	CcSEcCtD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.0048	0.00985	CbGpPWpGaD
Tazarotene—Haemoglobin—Hydroxyurea—brain cancer	0.00474	0.0164	CcSEcCtD
Tazarotene—Haemorrhage—Hydroxyurea—brain cancer	0.00472	0.0163	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.00466	0.00955	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00461	0.00944	CbGpPWpGaD
Tazarotene—CYP2C8—pituitary gland—brain cancer	0.00448	0.02	CbGeAlD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.00442	0.00906	CbGpPWpGaD
Tazarotene—Oedema—Procarbazine—brain cancer	0.00433	0.015	CcSEcCtD
Tazarotene—Photosensitivity reaction—Temozolomide—brain cancer	0.0042	0.0145	CcSEcCtD
Tazarotene—Erythema—Hydroxyurea—brain cancer	0.00411	0.0142	CcSEcCtD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00394	0.00809	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00389	0.00797	CbGpPWpGaD
Tazarotene—Haemoglobin—Carmustine—brain cancer	0.00383	0.0133	CcSEcCtD
Tazarotene—Haemorrhage—Carmustine—brain cancer	0.00381	0.0132	CcSEcCtD
Tazarotene—Oedema peripheral—Carmustine—brain cancer	0.00376	0.013	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00373	0.00764	CbGpPWpGaD
Tazarotene—Haemoglobin—Temozolomide—brain cancer	0.0037	0.0128	CcSEcCtD
Tazarotene—Pain—Procarbazine—brain cancer	0.0037	0.0128	CcSEcCtD
Tazarotene—Haemorrhage—Temozolomide—brain cancer	0.00368	0.0128	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.00366	0.0075	CbGpPWpGaD
Tazarotene—Oedema peripheral—Temozolomide—brain cancer	0.00363	0.0126	CcSEcCtD
Tazarotene—CYP2C8—endocrine gland—brain cancer	0.00347	0.0155	CbGeAlD
Tazarotene—Discomfort—Hydroxyurea—brain cancer	0.00345	0.012	CcSEcCtD
Tazarotene—Oedema—Hydroxyurea—brain cancer	0.00335	0.0116	CcSEcCtD
Tazarotene—Erythema—Carmustine—brain cancer	0.00332	0.0115	CcSEcCtD
Tazarotene—RARA—Adipogenesis—IRS2—brain cancer	0.00329	0.00675	CbGpPWpGaD
Tazarotene—Erythema—Temozolomide—brain cancer	0.00321	0.0111	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.00319	0.00655	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00313	0.00642	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00309	0.00634	CbGpPWpGaD
Tazarotene—Pruritus—Procarbazine—brain cancer	0.00306	0.0106	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.00306	0.00628	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.003	0.00616	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.00296	0.00608	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00287	0.00589	CbGpPWpGaD
Tazarotene—Pain—Hydroxyurea—brain cancer	0.00287	0.00992	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00276	0.00565	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00274	0.00562	CbGpPWpGaD
Tazarotene—Rash—Procarbazine—brain cancer	0.00273	0.00945	CcSEcCtD
Tazarotene—Dermatitis—Procarbazine—brain cancer	0.00273	0.00944	CcSEcCtD
Tazarotene—Oedema—Carmustine—brain cancer	0.00271	0.00938	CcSEcCtD
Tazarotene—Discomfort—Temozolomide—brain cancer	0.0027	0.00934	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00263	0.00539	CbGpPWpGaD
Tazarotene—Oedema—Temozolomide—brain cancer	0.00262	0.00906	CcSEcCtD
Tazarotene—CYP2C8—brain—brain cancer	0.00248	0.0111	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00237	0.00486	CbGpPWpGaD
Tazarotene—Pain—Carmustine—brain cancer	0.00232	0.00802	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.00227	0.00465	CbGpPWpGaD
Tazarotene—Pain—Temozolomide—brain cancer	0.00224	0.00775	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00223	0.00457	CbGpPWpGaD
Tazarotene—Discomfort—Etoposide—brain cancer	0.00216	0.00747	CcSEcCtD
Tazarotene—RARG—Generic Transcription Pathway—ESR2—brain cancer	0.00215	0.00442	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00214	0.00438	CbGpPWpGaD
Tazarotene—Rash—Hydroxyurea—brain cancer	0.00211	0.00732	CcSEcCtD
Tazarotene—Dermatitis—Hydroxyurea—brain cancer	0.00211	0.00731	CcSEcCtD
Tazarotene—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.0021	0.0043	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.00207	0.00424	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH2—brain cancer	0.00204	0.00418	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—CTNNB1—brain cancer	0.00198	0.00405	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—ESR2—brain cancer	0.00193	0.00396	CbGpPWpGaD
Tazarotene—Pruritus—Temozolomide—brain cancer	0.00185	0.00641	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—ESR2—brain cancer	0.00185	0.0038	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—ESR2—brain cancer	0.00185	0.0038	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH2—brain cancer	0.00183	0.00375	CbGpPWpGaD
Tazarotene—Pain—Etoposide—brain cancer	0.00179	0.0062	CcSEcCtD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH2—brain cancer	0.00175	0.0036	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH2—brain cancer	0.00175	0.0036	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.00173	0.00355	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT3—brain cancer	0.00172	0.00353	CbGpPWpGaD
Tazarotene—Rash—Carmustine—brain cancer	0.00171	0.00591	CcSEcCtD
Tazarotene—Dermatitis—Carmustine—brain cancer	0.00171	0.00591	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.00166	0.0034	CbGpPWpGaD
Tazarotene—Rash—Temozolomide—brain cancer	0.00165	0.00571	CcSEcCtD
Tazarotene—Dermatitis—Temozolomide—brain cancer	0.00165	0.00571	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.00153	0.00314	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.00151	0.0031	CbGpPWpGaD
Tazarotene—Pruritus—Etoposide—brain cancer	0.00148	0.00513	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.00147	0.00301	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.00145	0.00298	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.00133	0.00273	CbGpPWpGaD
Tazarotene—Rash—Etoposide—brain cancer	0.00132	0.00457	CcSEcCtD
Tazarotene—Dermatitis—Etoposide—brain cancer	0.00132	0.00457	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.00128	0.00262	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.00123	0.00251	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.0012	0.00246	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.00118	0.00241	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—DNMT1—brain cancer	0.00115	0.00237	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.00115	0.00236	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ESR2—brain cancer	0.00104	0.00213	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—DNMT1—brain cancer	0.00104	0.00212	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.00101	0.00207	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—DNMT1—brain cancer	0.000993	0.00204	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—DNMT1—brain cancer	0.000993	0.00204	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH2—brain cancer	0.000982	0.00201	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000966	0.00198	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ESR2—brain cancer	0.00093	0.00191	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ESR2—brain cancer	0.000892	0.00183	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ESR2—brain cancer	0.000892	0.00183	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH2—brain cancer	0.000881	0.00181	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH2—brain cancer	0.000844	0.00173	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH2—brain cancer	0.000844	0.00173	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SIRT1—brain cancer	0.000835	0.00171	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000805	0.00165	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SIRT1—brain cancer	0.000749	0.00154	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SIRT1—brain cancer	0.000718	0.00147	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SIRT1—brain cancer	0.000718	0.00147	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—MYC—brain cancer	0.000679	0.00139	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MYC—brain cancer	0.000609	0.00125	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000588	0.00121	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MYC—brain cancer	0.000584	0.0012	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—MYC—brain cancer	0.000584	0.0012	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2C9—brain cancer	0.000358	0.000735	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MYC—brain cancer	0.000327	0.000671	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—BSG—brain cancer	0.000305	0.000625	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MYC—brain cancer	0.000293	0.000601	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MYC—brain cancer	0.000281	0.000577	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MYC—brain cancer	0.000281	0.000577	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—IDH1—brain cancer	0.000262	0.000537	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000213	0.000437	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ENO2—brain cancer	0.000207	0.000425	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CG—brain cancer	9.5e-05	0.000195	CbGpPWpGaD
